Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	SEA	HSPG2 MUC3B MUC17 MUC16	1.47e-07	14	67	4	SM00200
Domain	SEA	HSPG2 MUC3B MUC17 MUC16	1.05e-06	22	67	4	PF01390
Domain	SEA	HSPG2 MUC3B MUC17 MUC16	1.27e-06	23	67	4	PS50024
Domain	SEA_dom	HSPG2 MUC3B MUC17 MUC16	1.27e-06	23	67	4	IPR000082
Domain	EGF_3	HSPG2 MUC3B ZAN MUC17 CNTNAP1 LRP6	1.96e-04	235	67	6	PS50026
Domain	EGF	HSPG2 MUC3B ZAN MUC17 CNTNAP1 LRP6	1.96e-04	235	67	6	SM00181
Domain	EGF-like_dom	HSPG2 MUC3B ZAN MUC17 CNTNAP1 LRP6	2.67e-04	249	67	6	IPR000742
Domain	EGF_1	HSPG2 MUC3B ZAN MUC17 CNTNAP1 LRP6	3.04e-04	255	67	6	PS00022
Domain	EGF-like_CS	HSPG2 MUC3B ZAN MUC17 CNTNAP1 LRP6	3.44e-04	261	67	6	IPR013032
Domain	EGF_2	HSPG2 MUC3B ZAN MUC17 CNTNAP1 LRP6	3.73e-04	265	67	6	PS01186
Domain	-	LMAN1L HSPG2 CNTNAP1 CLSTN2	3.77e-04	95	67	4	2.60.120.200
Domain	EGF	HSPG2 ZAN CNTNAP1 LRP6	1.09e-03	126	67	4	PF00008
Domain	WH2	WASF3 WIPF2	1.12e-03	14	67	2	SM00246
Domain	ConA-like_dom	LMAN1L HSPG2 ZAN CNTNAP1 CLSTN2	1.13e-03	219	67	5	IPR013320
Domain	-	MUC17 MUC16	1.29e-03	15	67	2	3.30.70.960
Domain	POU	POU3F1 POU2F3	1.47e-03	16	67	2	SM00352
Domain	POU_2	POU3F1 POU2F3	1.47e-03	16	67	2	PS00465
Domain	POU_dom	POU3F1 POU2F3	1.47e-03	16	67	2	IPR000327
Domain	POU_3	POU3F1 POU2F3	1.47e-03	16	67	2	PS51179
Domain	Pou	POU3F1 POU2F3	1.47e-03	16	67	2	PF00157
Domain	WH2	WASF3 WIPF2	1.47e-03	16	67	2	PF02205
Domain	POU_1	POU3F1 POU2F3	1.47e-03	16	67	2	PS00035
Domain	POU	POU3F1 POU2F3	1.67e-03	17	67	2	IPR013847
Domain	-	CNTNAP1 ZZEF1 F5	2.29e-03	73	67	3	2.60.120.260
Domain	FA58C	CNTNAP1 F5	2.55e-03	21	67	2	SM00231
Domain	FA58C_3	CNTNAP1 F5	2.55e-03	21	67	2	PS50022
Domain	WH2_dom	WASF3 WIPF2	2.55e-03	21	67	2	IPR003124
Domain	FA58C_1	CNTNAP1 F5	2.55e-03	21	67	2	PS01285
Domain	FA58C_2	CNTNAP1 F5	2.55e-03	21	67	2	PS01286
Domain	F5_F8_type_C	CNTNAP1 F5	3.33e-03	24	67	2	PF00754
Domain	FA58C	CNTNAP1 F5	3.33e-03	24	67	2	IPR000421
Domain	WH2	WASF3 WIPF2	3.33e-03	24	67	2	PS51082
Domain	Bromodomain_CS	SMARCA2 TRIM24	3.90e-03	26	67	2	IPR018359
Domain	-	POU3F1 POU2F3	4.20e-03	27	67	2	1.10.260.40
Domain	Galactose-bd-like	CNTNAP1 ZZEF1 F5	4.69e-03	94	67	3	IPR008979
Domain	Lambda_DNA-bd_dom	POU3F1 POU2F3	4.84e-03	29	67	2	IPR010982
Pathway	WP_KLEEFSTRA_SYNDROME	SMARCA2 SMARCC2 MBD5 RXRA	3.12e-06	29	50	4	M48076
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	TLK1 SMARCA2 CTBP1 MAML3	8.08e-05	65	50	4	M39682
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SOX5 TCF12 PER3 TLE3 SMARCA2 POU3F1 FBXL19 TRIM24 RFX2 POU2F3 CNOT2 RXRA PRDM1	1.05e-08	808	72	13	20412781
Pubmed	Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1.	TLE3 SMARCA2 SMARCC2 CTBP1 TRIM24	2.05e-08	40	72	5	34585037
Pubmed	Human transcription factor protein interaction networks.	SOX5 RNF214 HSPG2 TCF12 TLE3 SMARCA2 LRP6 SMARCC2 CTBP1 SPATA2 TRIM24 CNOT2 RXRA PRRC2B PRDM1	1.90e-07	1429	72	15	35140242
Pubmed	Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor.	SF3B1 TLE3 CTBP1 TRIM24 RXRA	3.90e-06	113	72	5	23403292
Pubmed	Knockdown of Brm and Baf170, Components of Chromatin Remodeling Complex, Facilitates Reprogramming of Somatic Cells.	SMARCA2 SMARCC2	4.23e-06	2	72	2	26121422
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TLE3 RBMS2 MAMLD1 SMARCA2 TRIM24 MAML3 CNOT2 PRRC2B	4.80e-06	457	72	8	32344865
Pubmed	Interaction network of human early embryonic transcription factors.	SOX5 TLE3 SMARCA2 SMARCC2 CTBP1 TRIM24 PRRC2B	8.43e-06	351	72	7	38297188
Pubmed	Loss of BAF (mSWI/SNF) Complexes Causes Global Transcriptional and Chromatin State Changes in Forebrain Development.	SOX5 SMARCA2 SMARCC2 POU3F1	1.04e-05	65	72	4	26655900
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC3B MUC17	1.27e-05	3	72	2	10512748
Pubmed	Matrix metalloproteinase-19 expression in keratinocytes is repressed by transcription factors Tst-1 and Skn-1a: implications for keratinocyte differentiation.	POU3F1 POU2F3	1.27e-05	3	72	2	17195013
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SOX5 TCF12 SMARCA2 POU3F1 NDRG2 POU2F3 MAML3 CNOT2 RXRA	1.57e-05	709	72	9	22988430
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 SYNRG FAM193B TLK1 MARK4 SPATA20 FBXL19 MAPKBP1 MBD5 ZZEF1 PRRC2B	1.63e-05	1105	72	11	35748872
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	SOX5 SUPT5H TLE3 SMARCA2 SMARCC2 CTBP1 TRIM24	1.89e-05	398	72	7	35016035
Pubmed	Development, maturation, and necessity of transcription factors in the mouse suprachiasmatic nucleus.	SOX5 TCF12 POU3F1 RXRA	2.04e-05	77	72	4	21525287
Pubmed	Interactions of RXR with coactivators are differentially mediated by helix 11 of the receptor's ligand binding domain.	TRIM24 RXRA	2.53e-05	4	72	2	11851396
Pubmed	Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin.	HSPG2 CNTNAP1	2.53e-05	4	72	2	25646087
Pubmed	Peroxisome proliferator-activated receptor gamma ligands enhance human B cell antibody production and differentiation.	RXRA PRDM1	2.53e-05	4	72	2	19915048
Pubmed	Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation.	POU3F1 POU2F3	2.53e-05	4	72	2	9242494
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SF3B1 NHSL2 CNTNAP1 PPP1R3F SMARCC2 SPATA20 CTBP1 GOLGA2 PRRC2B PHACTR1	2.87e-05	963	72	10	28671696
Pubmed	Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.	TLK1 TCF12 SUPT5H SMARCC2 CTBP1	3.52e-05	178	72	5	27637333
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	HSPG2 FAM193B ACD SMARCC2 CTBP1 MAPKBP1 PRRC2B PRDM1	3.73e-05	608	72	8	16713569
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	SYNRG TLK1 TCF12 SF3B1 TLE3 MAMLD1 TRIM24	3.80e-05	444	72	7	34795231
Pubmed	The POU domain transcription factors Oct-6 and Oct-11 negatively regulate loricrin gene expression in keratinocytes: association with AP-1 and Sp1/Sp3.	POU3F1 POU2F3	4.21e-05	5	72	2	23341029
Pubmed	Testing for association between MeCP2 and the brahma-associated SWI/SNF chromatin-remodeling complex.	SMARCA2 SMARCC2	6.31e-05	6	72	2	16940996
Pubmed	The putative cofactor TIF1alpha is a protein kinase that is hyperphosphorylated upon interaction with liganded nuclear receptors.	TRIM24 RXRA	6.31e-05	6	72	2	9632676
Pubmed	The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest.	SMARCA2 SMARCC2	6.31e-05	6	72	2	16230384
Pubmed	Activation of ATP-binding cassette transporter A1 transcription by chromatin remodeling complex.	SMARCA2 RXRA	6.31e-05	6	72	2	15774904
Pubmed	A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.	TRIM24 RXRA	6.31e-05	6	72	2	10610177
Pubmed	The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18.	TRIM24 RXRA	6.31e-05	6	72	2	7744009
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	TCF12 SUPT5H CTBP1 FBXL19 TRIM24 RFX2 MAML3 CNOT2 RXRA	8.13e-05	877	72	9	20211142
Pubmed	Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter.	SMARCA2 SMARCC2	8.82e-05	7	72	2	16601680
Pubmed	BRIT1/MCPH1 links chromatin remodelling to DNA damage response.	SMARCA2 SMARCC2	8.82e-05	7	72	2	19525936
Pubmed	Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1.	TRIM24 RXRA	8.82e-05	7	72	2	8598193
Pubmed	Synergistic activation of steroidogenic acute regulatory protein expression and steroid biosynthesis by retinoids: involvement of cAMP/PKA signaling.	RXRA STAR	8.82e-05	7	72	2	24265455
Pubmed	Epigenetic regulation by BAF (mSWI/SNF) chromatin remodeling complexes is indispensable for embryonic development.	SMARCA2 SMARCC2	1.17e-04	8	72	2	26986003
Pubmed	Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex.	SOX5 NEO1 TLE3 POU3F1	1.40e-04	126	72	4	16284245
Pubmed	Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.	TLE3 SMARCA2 SMARCC2 CTBP1	1.62e-04	131	72	4	34551306
Pubmed	Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes.	SOX5 SMARCC2 CTBP1	1.85e-04	53	72	3	21532573
Pubmed	Natural helix 9 mutants of PPARγ differently affect its transcriptional activity.	TRIM24 RXRA	1.88e-04	10	72	2	30595551
Pubmed	Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes.	SMARCA2 SMARCC2	1.88e-04	10	72	2	11238380
Pubmed	Human Ccr4-Not complex is a ligand-dependent repressor of nuclear receptor-mediated transcription.	CNOT2 RXRA	1.88e-04	10	72	2	16778766
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TLE3 MARK4 MAPKBP1 SPATA2 CLEC16A PRRC2B	2.02e-04	407	72	6	12693553
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	NEO1 TCF12 SF3B1 MUC16 CTBP1 SPATA2 CLEC16A PRRC2B	2.03e-04	777	72	8	35844135
Pubmed	Functional proteomics mapping of a human signaling pathway.	SOX5 HSPG2 SF3B1 MAST4 SUPT5H ZZEF1 RXRA	2.24e-04	591	72	7	15231748
Pubmed	Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis.	HSPG2 NEO1	2.30e-04	11	72	2	15186747
Pubmed	A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus.	CLEC16A PRDM1	2.30e-04	11	72	2	19838195
Pubmed	Targeting HIV transcription: the quest for a functional cure.	SUPT5H SMARCA2	2.30e-04	11	72	2	25731772
Pubmed	CNS/PNS boundary transgression by central glia in the absence of Schwann cells or Krox20/Egr2 function.	CNTNAP1 POU3F1	2.30e-04	11	72	2	20427655
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TLE3 SMARCA2 SMARCC2 TRIM24 PRRC2B	2.40e-04	268	72	5	33640491
Pubmed	SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones.	SMARCA2 SMARCC2	2.75e-04	12	72	2	11734557
Pubmed	SoxD transcription factor deficiency in Schwann cells delays myelination in the developing peripheral nervous system.	SOX5 POU3F1	2.75e-04	12	72	2	34234180
Pubmed	A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency.	SF3B1 SMARCA2 SMARCC2	2.81e-04	61	72	3	20305087
Pubmed	WW domains provide a platform for the assembly of multiprotein networks.	SF3B1 TLE3 SMARCC2 WIPF2	3.01e-04	154	72	4	16055720
Pubmed	Genome-wide association analysis identifies three psoriasis susceptibility loci.	FBXL19 SPATA2	3.25e-04	13	72	2	20953189
Pubmed	TIF1delta, a novel HP1-interacting member of the transcriptional intermediary factor 1 (TIF1) family expressed by elongating spermatids.	TRIM24 RXRA	3.25e-04	13	72	2	15322135
Pubmed	A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors.	TRIM24 RXRA	3.25e-04	13	72	2	8978696
Pubmed	Separation and Quantification of Some Alkaloids from Fumaria parviflora by Capillary Isotachophoresis1.	SMARCA2 SMARCC2	3.25e-04	13	72	2	17340523
Pubmed	WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination.	WASF3 CNTNAP1	3.25e-04	13	72	2	16723544
Pubmed	Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1.	TRIM24 RXRA	3.25e-04	13	72	2	9115274
Pubmed	Neurog2 simultaneously activates and represses alternative gene expression programs in the developing neocortex.	SOX5 TLE3	3.25e-04	13	72	2	22735158
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TLE3 SMARCA2 MUC16 SMARCC2 TRIM24 MAML3 PRRC2B	3.55e-04	638	72	7	31182584
Pubmed	Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome.	SMARCA2 SMARCC2	3.78e-04	14	72	2	36289231
Pubmed	The protein kinase KIS impacts gene expression during development and fear conditioning in adult mice.	GABRG1 SF3B1	3.78e-04	14	72	2	22937132
Pubmed	Purification and biochemical heterogeneity of the mammalian SWI-SNF complex.	SMARCA2 SMARCC2	3.78e-04	14	72	2	8895581
Pubmed	Congenital hypomyelinating neuropathy with lethal conduction failure in mice carrying the Egr2 I268N mutation.	CNTNAP1 POU3F1	3.78e-04	14	72	2	19244508
Pubmed	A developmental transcriptomic analysis of Pax1 and Pax9 in embryonic intervertebral disc development.	SOX5 HSPG2	3.78e-04	14	72	2	28011632
Pubmed	Gene expression analysis of the late embryonic mouse cerebral cortex using DNA microarray: identification of several region- and layer-specific genes.	SOX5 TLE3 POU3F1	4.04e-04	69	72	3	15142957
Pubmed	Kinetic analysis of npBAF to nBAF switching reveals exchange of SS18 with CREST and integration with neural developmental pathways.	SMARCA2 SMARCC2	4.36e-04	15	72	2	23785148
Pubmed	Cyclin E associates with BAF155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest.	SF3B1 SMARCA2	4.36e-04	15	72	2	9891079
Pubmed	An essential switch in subunit composition of a chromatin remodeling complex during neural development.	SMARCA2 SMARCC2	4.36e-04	15	72	2	17640523
Pubmed	Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit.	SMARCA2 RXRA	4.36e-04	15	72	2	14701856
Pubmed	The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression.	SMARCA2 SMARCC2	4.36e-04	15	72	2	11263494
Pubmed	Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation.	SMARCA2 SMARCC2	4.36e-04	15	72	2	11175787
Pubmed	Regulation of dendritic development by neuron-specific chromatin remodeling complexes.	SMARCA2 SMARCC2	4.36e-04	15	72	2	17920018
Pubmed	New semidominant mutations that affect mouse development.	SOX5 LRP6	4.98e-04	16	72	2	15384171
Pubmed	A human RNA polymerase II complex containing factors that modify chromatin structure.	SMARCA2 SMARCC2	4.98e-04	16	72	2	9710619
Pubmed	Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor.	TLK1 TLE3 RXRA GOLGA2	4.99e-04	176	72	4	27229929
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FAM193B TLK1 PER3 MBD5 NDRG2 MAML3	5.58e-04	493	72	6	15368895
Pubmed	Identification of a polymorphic, neuron-specific chromatin remodeling complex.	SMARCA2 SMARCC2	5.63e-04	17	72	2	12368262
Pubmed	The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes.	SMARCA2 SMARCC2	5.63e-04	17	72	2	11078522
Pubmed	A census of human transcription factors: function, expression and evolution.	SOX5 TCF12 POU3F1 FOXI3 RFX2 POU2F3 RXRA PRDM1	5.73e-04	908	72	8	19274049
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	TLE3 SMARCA2 SMARCC2	5.79e-04	78	72	3	28611094
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	TLK1 SF3B1 PER3 SMARCA2 SMARCC2 KIF24 CNOT2 GOLGA2 PRRC2B	6.20e-04	1155	72	9	20360068
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC17 MUC16	6.33e-04	18	72	2	18834073
Pubmed	Ablation of BAF170 in Developing and Postnatal Dentate Gyrus Affects Neural Stem Cell Proliferation, Differentiation, and Learning.	SMARCA2 SMARCC2	6.33e-04	18	72	2	27392482
Pubmed	mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad.	SMARCA2 SMARCC2	6.33e-04	18	72	2	14559996
Pubmed	Mamld1 deficiency significantly reduces mRNA expression levels of multiple genes expressed in mouse fetal Leydig cells but permits normal genital and reproductive development.	MAMLD1 STAR	6.33e-04	18	72	2	23087174
Pubmed	TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation.	SMARCA2 SMARCC2	6.33e-04	18	72	2	28068325
Pubmed	BAF complexes facilitate decatenation of DNA by topoisomerase IIα.	SMARCA2 SMARCC2	6.33e-04	18	72	2	23698369
Pubmed	Sox5 and Sox6 are required for notochord extracellular matrix sheath formation, notochord cell survival and development of the nucleus pulposus of intervertebral discs.	SOX5 HSPG2	6.33e-04	18	72	2	12571105
Pubmed	Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex.	SOX5 POU3F1 CLSTN2	6.70e-04	82	72	3	31073041
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	TLE3 SMARCA2 TRIM24	6.94e-04	83	72	3	28794006
Pubmed	Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction.	SMARCA2 SMARCC2	7.06e-04	19	72	2	16932743
Pubmed	Genome-wide association study for refractive astigmatism reveals genetic co-determination with spherical equivalent refractive error: the CREAM consortium.	ABCA13 CLSTN2	7.06e-04	19	72	2	25367360
Pubmed	Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes.	SMARCA2 SMARCC2	7.06e-04	19	72	2	12110891
Pubmed	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	ALPK3 RXRA PRDM1	7.44e-04	85	72	3	23648065
Pubmed	Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix.	SMARCA2 SMARCC2	7.84e-04	20	72	2	9128241
Pubmed	Transcriptional regulation of cortical neuron migration by POU domain factors.	TLE3 POU3F1	7.84e-04	20	72	2	11859196
Pubmed	Loss of BAF Complex in Developing Cortex Perturbs Radial Neuronal Migration in a WNT Signaling-Dependent Manner.	SMARCA2 SMARCC2	7.84e-04	20	72	2	34220450
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	TRIM24 RXRA	7.84e-04	20	72	2	11877444
Interaction	NCOR1 interactions	SOX5 SUPT5H TLE3 SMARCA2 SMARCC2 CTBP1 CNOT2 RXRA GOLGA2 PRDM1	4.83e-07	363	70	10	int:NCOR1
Interaction	HELZ interactions	RNF214 TLE3 RBMS2 CTBP1 FBXL19 TRIM24 CNOT2 PRRC2B	2.99e-06	257	70	8	int:HELZ
Interaction	NCOR2 interactions	SOX5 SUPT5H TLE3 CTBP1 CNOT2 RXRA GOLGA2 PRDM1	3.65e-06	264	70	8	int:NCOR2
Interaction	GATA2 interactions	TLE3 SMARCA2 SMARCC2 TRIM24 RXRA GOLGA2 PRRC2B	5.83e-06	199	70	7	int:GATA2
Interaction	SOX7 interactions	SOX5 TLE3 SMARCA2 SMARCC2 TRIM24	9.70e-06	82	70	5	int:SOX7
Interaction	ATXN1L interactions	SOX5 TLE3 SMARCC2 CTBP1 PRRC2B PRDM1	1.36e-05	150	70	6	int:ATXN1L
Interaction	EGR2 interactions	SOX5 TLE3 SMARCA2 TRIM24 GOLGA2 PRRC2B	2.86e-05	171	70	6	int:EGR2
Interaction	RNF214 interactions	RNF214 SUPT5H CNOT2 GOLGA2 PRRC2B	3.08e-05	104	70	5	int:RNF214
Interaction	HNF1B interactions	SOX5 TLE3 SMARCA2 TRIM24 PRRC2B PRDM1	5.16e-05	190	70	6	int:HNF1B
Interaction	MYOD1 interactions	TCF12 TLE3 SMARCA2 SMARCC2 TRIM24 RXRA	5.79e-05	194	70	6	int:MYOD1
Interaction	ETS1 interactions	TLE3 SMARCA2 SMARCC2 TRIM24 PRDM1	6.36e-05	121	70	5	int:ETS1
Interaction	BICRA interactions	SUPT5H SMARCA2 SMARCC2 GOLGA2	8.67e-05	67	70	4	int:BICRA
Interaction	NFIC interactions	SOX5 SF3B1 TLE3 SMARCA2 TRIM24 PRDM1	8.97e-05	210	70	6	int:NFIC
Interaction	GCM1 interactions	TLE3 SMARCA2 SMARCC2 PRRC2B	9.19e-05	68	70	4	int:GCM1
Interaction	HDAC3 interactions	SF3B1 SUPT5H CTBP1 CLEC16A CNOT2 RXRA GOLGA2	1.06e-04	313	70	7	int:HDAC3
Interaction	NUP35 interactions	TLE3 RBMS2 MAMLD1 SMARCA2 TRIM24 MAML3 CNOT2 PRRC2B	1.08e-04	424	70	8	int:NUP35
Interaction	MEX3B interactions	RNF214 FAM193B RBMS2 SPATA2 CNOT2 PRRC2B	1.22e-04	222	70	6	int:MEX3B
Interaction	ERG interactions	SF3B1 TLE3 SMARCA2 SMARCC2 TRIM24 PRRC2B	1.25e-04	223	70	6	int:ERG
Interaction	TSHZ3 interactions	SOX5 TLE3 CTBP1 GOLGA2	1.28e-04	74	70	4	int:TSHZ3
Interaction	NFIX interactions	SOX5 TLE3 SMARCA2 SMARCC2 TRIM24 PRDM1	1.37e-04	227	70	6	int:NFIX
Interaction	SS18L2 interactions	SMARCA2 SMARCC2 MBD5 CNOT2	1.42e-04	76	70	4	int:SS18L2
Interaction	PUM2 interactions	RNF214 RBMS2 TRIM24 CNOT2 PRRC2B	1.45e-04	144	70	5	int:PUM2
Interaction	GPS2 interactions	SUPT5H TLE3 RFX2 CNOT2 GOLGA2	1.45e-04	144	70	5	int:GPS2
Interaction	POU5F1 interactions	SOX5 HSPG2 SMARCA2 MUC16 SMARCC2 CTBP1 TRIM24 RFX2 PRRC2B	1.83e-04	584	70	9	int:POU5F1
Interaction	GSE1 interactions	SOX5 SUPT5H TLE3 GOLGA2 PRDM1	1.98e-04	154	70	5	int:GSE1
Interaction	CREBBP interactions	TCF12 TLE3 SMARCA2 SMARCC2 CTBP1 FBXL19 TRIM24 POU2F3 RXRA	2.20e-04	599	70	9	int:CREBBP
Interaction	KDM2B interactions	SOX5 SUPT5H CTBP1 GOLGA2 PRDM1	2.43e-04	161	70	5	int:KDM2B
Interaction	JMJD1C interactions	SUPT5H CNOT2 RXRA GOLGA2	2.50e-04	88	70	4	int:JMJD1C
Interaction	FOXP1 interactions	SOX5 RBMS2 SMARCA2 CTBP1 GOLGA2 PRDM1	2.63e-04	256	70	6	int:FOXP1
Interaction	PAX6 interactions	SOX5 TLK1 TLE3 SMARCA2 SMARCC2 TRIM24 PRRC2B	2.76e-04	366	70	7	int:PAX6
Interaction	DYRK1B interactions	PPP1R3F CTBP1 CLEC16A KIF24	2.84e-04	91	70	4	int:DYRK1B
Interaction	RCOR3 interactions	SOX5 SUPT5H CTBP1 GOLGA2 PRDM1	3.30e-04	172	70	5	int:RCOR3
GeneFamily	CD molecules\|Mucins	MUC3B MUC17 MUC16	1.30e-05	21	40	3	648
GeneFamily	Cadherin related	CDHR5 CLSTN2	6.36e-04	17	40	2	24
GeneFamily	POU class homeoboxes and pseudogenes	POU3F1 POU2F3	1.17e-03	23	40	2	523
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4-Tregs\|bone_marrow / Manually curated celltypes from each tissue	RNF214 TLK1 MAST4 PPP1R3F F5 PRDM1	5.44e-07	187	71	6	bda716a64262325e6e68b281caf131f1840fd298
ToppCell	COPD-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	NEO1 MAST4 RBMS2 PHACTR1 PRDM1	1.58e-05	197	71	5	30dbc05ea66892d2e18ff375ffa86d1db7bc4083
ToppCell	mild-Treg\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TLK1 MAST4 PPP1R3F F5 PRDM1	1.58e-05	197	71	5	39800e6e83f2d333b753d121c7aeb2912b91faa2
ToppCell	mild-Treg\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TLK1 MAST4 PPP1R3F F5 PRDM1	1.61e-05	198	71	5	0269617c0628003d2a13dab98abfd2d15775d16a
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SPATC1 GABRG1 MAST4 RFX2 NDRG2	1.69e-05	200	71	5	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SPATC1 GABRG1 MAST4 RFX2 NDRG2	1.69e-05	200	71	5	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SPATC1 GABRG1 MAST4 RFX2 NDRG2	1.69e-05	200	71	5	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SPATC1 GABRG1 MAST4 RFX2 NDRG2	1.69e-05	200	71	5	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SPATC1 GABRG1 MAST4 RFX2 NDRG2	1.69e-05	200	71	5	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SPATC1 GABRG1 MAST4 RFX2 NDRG2	1.69e-05	200	71	5	01819446deeab9054f5cfe889d53bb49d137dbc0
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MUC17 CNTNAP1 FOXI3 RFX2	8.28e-05	144	71	4	f769be4da268980ea7c06d7097ec39d06777e675
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ABCA13 CLSTN2 HUNK	8.50e-05	145	71	4	8da10bc6611976e1ec85e09f04a2dc5bf6555c9e
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	ABCA13 MUC16 FOXI3 RFX2	9.95e-05	151	71	4	8216462e723fec2797387929dde095370947e10a
ToppCell	Control-Treg\|World / Disease group and Cell class	SOX5 TLK1 MAST4 ALPK3	1.27e-04	161	71	4	ead9f5a491321f9e307f7c97e47a4ca124f59bb6
ToppCell	facs-Thymus-Epithelium-3m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM229A MANSC4 CDHR5 POU2F3	1.30e-04	162	71	4	3dc39db0d5f6f3d7bcc312a6bce7aaeb914138d1
ToppCell	facs-Thymus-Epithelium-3m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM229A MANSC4 CDHR5 POU2F3	1.30e-04	162	71	4	0a7138266054ea5954649c8b61ef93905d56b068
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GABRG1 ZAN ABCA13 F5	1.30e-04	162	71	4	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	facs-Thymus-Epithelium-3m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM229A MANSC4 CDHR5 POU2F3	1.30e-04	162	71	4	25323785dd33337bcefd05958a4a1a208a9ceb04
ToppCell	healthy_donor-Myeloid-Monocytic-Neutrophil\|healthy_donor / Disease condition, Lineage, Cell class and subclass	TLE3 FAM157C FAM157B FAM157A	1.50e-04	168	71	4	04259f5a9b067cd1b5619e34591e4b2fccc18535
ToppCell	COVID-19_Moderate-Treg\|World / disease group, cell group and cell class	PPP1R3F CLSTN2 F5 PRDM1	1.53e-04	169	71	4	27ad11239559b025bef582f89b2a83501d9d3993
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-promyelocyte\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	NEO1 SMARCA2 GOLGA2 STAR	1.53e-04	169	71	4	f33f4a0baad1b3cb5be61dfc7b00c7a3845f7120
ToppCell	Tuft-tuft-4\|World / Class top	PER3 MAMLD1 PPP1R3F PRDM1	1.72e-04	174	71	4	d6f306ebf66061bf9e9742000bfedce12d277452
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HSPG2 MAST4 NHSL2 SMARCA2	1.79e-04	176	71	4	77516048aefbe1f48e825052756df0c310c1c486
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA13 CLSTN2 HUNK MAML3	1.83e-04	177	71	4	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1\|TCGA-Liver / Sample_Type by Project: Shred V9	NEO1 RBMS2 HUNK MBD5	1.87e-04	178	71	4	51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Treg\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TLK1 MAST4 F5 PRDM1	1.87e-04	178	71	4	e37142a84d9713ff1571ce9f976842bf5c17c86f
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAM193B NEO1 PER3 MAML3	1.87e-04	178	71	4	c87945146b2734141f07b39d268e0d8086ee0364
ToppCell	3'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAM193B RFX2 PHACTR1 PRDM1	1.91e-04	179	71	4	2285e3a9018a60d7f6e974fee46b6f61d39aa76f
ToppCell	3'-Adult-Appendix-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAM193B RFX2 PHACTR1 PRDM1	1.91e-04	179	71	4	0b0f27d7c5cc5ae7618d887dcfa7219df8ff1935
ToppCell	3'-Adult-Appendix-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAM193B RFX2 PHACTR1 PRDM1	1.91e-04	179	71	4	63bc819df62b1f8f37bf1f17bdd4fcc161886923
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TLK1 MAST4 F5 PRDM1	1.95e-04	180	71	4	6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	SOX5 MAST4 HUNK PHACTR1	1.95e-04	180	71	4	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX5 CLSTN2 HUNK CLEC16A	2.08e-04	183	71	4	0e8fb371d8eac777451c76f41d53577f5dfb740d
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX5 CLSTN2 HUNK CLEC16A	2.08e-04	183	71	4	cbc3b00faa7e4e0dbbbc8ee105467c65241c7470
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX5 FAM131C HUNK PRDM1	2.12e-04	184	71	4	2ba98708dfd7f1b2a661578a334684094ff453ad
ToppCell	wk_20-22-Epithelial-PNS-intermediate_Schwann\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	HSPG2 MAMLD1 POU3F1 CLSTN2	2.12e-04	184	71	4	4e3ba64692868563a579902aa9c6f88cab5bce26
ToppCell	facs-Heart-LA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LMAN1L POU3F1 CLSTN2 POU2F3	2.21e-04	186	71	4	e2ba9f3518d87a44537a57a648df17ab98fbbb39
ToppCell	COPD-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	SOX5 MAST4 ABCA13 MUC16	2.21e-04	186	71	4	d75fe7640a4b2c450c9759a1b3c3ef2a087f0092
ToppCell	facs-Heart-LA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LMAN1L POU3F1 CLSTN2 POU2F3	2.21e-04	186	71	4	fda3415222f688ef5cd8de4b0b79daa2493c585f
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAST4 ABCA13 POU2F3 CLEC16A	2.21e-04	186	71	4	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MAST4 PPP1R3F F5 PRDM1	2.31e-04	188	71	4	9db3d3010cb8a1f3ee1cdccaf3cbaac3cf983fc5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NHSL2 CLSTN2 F5 MAML3	2.31e-04	188	71	4	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 CNTNAP1 MAMLD1 AMTN	2.31e-04	188	71	4	32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	MAST4 PPP1R3F F5 PRDM1	2.31e-04	188	71	4	72be6fe654f3a5f654d3b9680145bce7ae9b721d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NHSL2 CLSTN2 F5 MAML3	2.31e-04	188	71	4	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	COVID-19_Mild-Lymphoid_T/NK-Treg\|COVID-19_Mild / Disease group, lineage and cell class	MAST4 PPP1R3F F5 PRDM1	2.31e-04	188	71	4	42553fdc127e5f613ffd5067620a768a40f1a8a1
ToppCell	P28-Mesenchymal-developing_mesenchymal_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SOX5 CLSTN2 HUNK NDRG2	2.31e-04	188	71	4	e7681efb4d2de7f1d8a89552fff76a829376bf1b
ToppCell	MS-Treg-CD4_Treg\|MS / Condition, Cell_class and T cell subcluster	RNF214 TLK1 MAST4 F5	2.35e-04	189	71	4	b1310eed6113b3536868340a5b2b2587ad377fa9
ToppCell	MS-Treg\|MS / Condition, Cell_class and T cell subcluster	RNF214 TLK1 MAST4 F5	2.35e-04	189	71	4	3fa79242fb3dba4a3f52276da0124ba260423fb6
ToppCell	COVID-19_Mild-Treg\|COVID-19_Mild / Disease condition and Cell class	MAST4 PPP1R3F F5 PRDM1	2.35e-04	189	71	4	f0fceb5f87ca260bfe038c0db3487a6d2e1b0a6e
ToppCell	ILEUM-non-inflamed-(1)_Tregs\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TLK1 MAST4 F5 PRDM1	2.45e-04	191	71	4	e065d16a1f88c91dec576d248a318534ceab1cb2
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SOX5 MAST4 LRP6 PHACTR1	2.45e-04	191	71	4	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-Treg\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TLK1 MAST4 F5 PRDM1	2.50e-04	192	71	4	b7e08cadb50f66c2efdde45e0fa8bab29367269b
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Vein\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 MAMLD1 F5 PHACTR1	2.50e-04	192	71	4	81baf1c4063469bb0c03a8602b40e387ba7b0dfb
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	SOX5 MAST4 LRP6 PHACTR1	2.50e-04	192	71	4	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	ILEUM-inflamed-(1)_Tregs\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TLK1 MAST4 F5 PRDM1	2.50e-04	192	71	4	1fe3417dfd1cf1758fd82c9ac13dbd88bdf0b548
ToppCell	Control-Lymphoid_T/NK-Treg\|Control / Disease group, lineage and cell class	RNF214 MAST4 F5 PRDM1	2.55e-04	193	71	4	715f2bbee12a7952cba85d9cd8820411983ce790
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	LRP6 HUNK TRIM24 F5	2.55e-04	193	71	4	503a979328c68b096680b71359a26f02fafdff35
ToppCell	LA\|World / Chamber and Cluster_Paper	SOX5 LMAN1L WASF3 CLSTN2	2.55e-04	193	71	4	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 MAMLD1 F5 PHACTR1	2.55e-04	193	71	4	7261c1ce30c796b61c6ec58e64a051baa24732ff
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	RNF214 MAST4 F5 PRDM1	2.60e-04	194	71	4	2faf49d85d09932c9c20d9f675c8093ad802fae5
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RNF214 MAST4 F5 PRDM1	2.60e-04	194	71	4	fd3d5ac94de3db7136684c86f8589631ad87e6d8
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_Tregs\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TLK1 MAST4 F5 PRDM1	2.60e-04	194	71	4	0396457834bbfed8d0b9b2ddaaecd9f28e1d56ed
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 RBMS2 RFX2 PHACTR1	2.65e-04	195	71	4	818bc18c5834238e5f733cac6fe928ed0788f57d
ToppCell	COVID-19-Lymphoid-Tregs\|COVID-19 / Condition, Lineage and Cell class	TLK1 MAST4 F5 PRDM1	2.65e-04	195	71	4	284cfff4d59ecc1430997b118de17fee167dcbb1
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	SOX5 TCF12 MBD5 MAML3	2.70e-04	196	71	4	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	myeloid-Monocyte\|myeloid / Lineage, cell class and subclass	LILRA6 RFX2 F5 RXRA	2.75e-04	197	71	4	6acf059cee6ba6bdeacc089b090d72336790972a
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-F_2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TLK1 MAST4 F5 PRDM1	2.75e-04	197	71	4	54fb7197db3c0dc87a1114e1ab1d2bfafd564b35
ToppCell	control-Treg\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF214 MAST4 F5 PRDM1	2.75e-04	197	71	4	a80674a0b996aa57d52bfff7264c57caf4c31cc6
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 MUC16 HUNK NDRG2	2.81e-04	198	71	4	28ada093cec552262731194a04a4b9ff93186c3b
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TLK1 MAST4 F5 PRDM1	2.81e-04	198	71	4	03423d6c614440b9c738f75ac3f5a6941719a279
ToppCell	severe-Treg\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MAST4 PPP1R3F F5 PRDM1	2.81e-04	198	71	4	377980b9f7d02818e1d145e6884604f8bfacc4f2
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	SOX5 TCF12 MBD5 MAML3	2.81e-04	198	71	4	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAST4 PPP1R3F F5 PRDM1	2.81e-04	198	71	4	d021d0edb6aba2f15c51a3ec4e08c7233d0c1962
ToppCell	severe-Treg\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TLK1 MAST4 F5 PRDM1	2.81e-04	198	71	4	4935b40fc848037a06055f30d90bde940b9d5321
ToppCell	3'_v3-Lung-Myeloid_Monocytic-Classical_monocytes\|Lung / Manually curated celltypes from each tissue	TLE3 LILRA6 F5 RXRA	2.86e-04	199	71	4	bfd0d171ea6bb7abd5cdfeac22608cc190aaa2be
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-Treg\|Leuk-UTI / Disease, condition lineage and cell class	RNF214 TLK1 F5 PRDM1	2.86e-04	199	71	4	100f45e04f284551b29ef0406476bdc347ddbf7e
ToppCell	Control-Control-Lymphocyte-T/NK-Treg\|Control / Disease, condition lineage and cell class	RNF214 MAST4 F5 PRDM1	2.86e-04	199	71	4	6b7eb14bf03aa05f2d4ac4f5dd1ccf41a7e47bd1
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	SOX5 TCF12 MBD5 MAML3	2.86e-04	199	71	4	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	severe-HLA-DR-_S100A+_Monocyte\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TLE3 RFX2 F5 RXRA	2.92e-04	200	71	4	a5eb50cbf3e94f0b3aa0fbef888989a11cffea37
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-Treg\|COVID-19_Mild / Disease, condition lineage and cell class	MAST4 PPP1R3F F5 PRDM1	2.92e-04	200	71	4	c6ae15f7deba26008af5b647855675003bb2ebcd
ToppCell	Control_saline-Endothelial-Endothelial-Artery\|Control_saline / Treatment groups by lineage, cell group, cell type	SOX5 MAST4 MAMLD1 F5	2.92e-04	200	71	4	65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCA2 SMARCC2	2.09e-04	9	72	2	DOID:0050340 (implicated_via_orthology)
Disease	Coffin-Siris syndrome	SMARCA2 SMARCC2	4.50e-04	13	72	2	C0265338
Disease	histidine measurement	RBMS2 NDRG2 CNOT2	5.71e-04	66	72	3	EFO_0009769
Disease	Non-steroidal anti-inflammatory and antirheumatic product use measurement	LMAN1L MAML3	6.04e-04	15	72	2	EFO_0009935
Disease	total blood protein measurement	SOX5 TLK1 TLE3 MARK4 FBXL19 CLEC16A	8.04e-04	449	72	6	EFO_0004536
Disease	coagulation factor V measurement	MAST4 F5	1.08e-03	20	72	2	EFO_0008087
Disease	gamma-glutamylglutamine measurement	RBMS2 MAML3	1.31e-03	22	72	2	EFO_0021138
Disease	Adenoid Cystic Carcinoma	TLK1 SMARCA2 MAML3	1.90e-03	100	72	3	C0010606
Disease	immature platelet count	TLK1 RBMS2 MARK4	2.24e-03	106	72	3	EFO_0803544
Disease	glucose measurement	SOX5 LMAN1L ZAN MANSC4 CTBP1	2.38e-03	380	72	5	EFO_0004468
Disease	Malignant mesothelioma	SF3B1 SMARCA2 RXRA	2.43e-03	109	72	3	C0345967
Disease	platelet component distribution width	LMAN1L TLK1 WASF3 MARK4 MAMLD1 ZZEF1 RFX2	2.44e-03	755	72	7	EFO_0007984

Protein segments in the cluster

Peptide	Gene	Start	Entry
LMPHSGLSRPSSCPG	nan	31	Q75L30
MLPSSTPGPGHATET	FAM229A	1	H3BQW9
MSLGSSPIQPRPGHT	CNTNAP1	236	P78357
VPSAMSLSHGLPPVA	CTBP1	401	Q13363
SPSPLPSVTGHRTSM	GJA10	466	Q969M2
VPTMPSLPGTGLTAS	ALPK3	1066	Q96L96
LGLGTPTQSHPPETM	ALPK3	1116	Q96L96
SMLTGLHPPTSGTII	ABCA13	3886	Q86UQ4
PAAGMTPGTQTHPLT	AMTN	71	Q6UX39
MPPGVGTSTSHQPAT	CDHR5	551	Q9HBB8
QPGSGSMPLFPSIHL	CLSTN2	271	Q9H4D0
LLTPPMSSSSRGPGA	FBXL19	16	Q6PCT2
SAGSPSAPGSSMPIR	HSPG2	2716	P98160
PSGSVLTPGMDHPIS	RBMS2	316	Q15434
TTVPTLTHSPGMPET	MUC16	11756	Q8WXI7
STASSPGGPMLTSTP	FOXI3	296	A8MTJ6
KMTSPPRGPGTHRTA	MCCD1	51	P59942
HPVGLPRTTGPMQSS	MAML3	696	Q96JK9
IPSTPGRGGHLSMSL	LMAN1L	361	Q9HAT1
STGSPPMKNPSHPTA	PER3	991	P56645
GSPPMKNPSHPTAST	PER3	1011	P56645
MGPLFTTIPGAHSGP	FAM157A	1	C9JC47
PGTHPGLSETTNPMG	TCF12	666	Q99081
MGPLFTTIPGAHSGP	FAM157C	1	P0CG43
GSTAHHLGPAMSPSP	POU3F1	131	Q03052
HMGVPHSGPTLTPRT	KIF24	1196	Q5T7B8
VPHPSSLSGSLPGMS	LRP6	1426	O75581
TKLSHMPVPPGLNSS	MANSC4	241	A6NHS7
LMVSGHSGGSSLPPT	LILRA6	416	Q6PI73
LPGGVPSPGASLTSM	GOLGA2	86	Q08379
GSLGPLSVPPVHSTM	POU2F3	361	Q9UKI9
LPSTTGSLPMHPSGC	PHACTR1	296	Q9C0D0
MGPLFTTIPGAHSGP	FAM157B	1	P0CG42
ASMTPGLHPGSTLIP	GABRG1	376	Q8N1C3
PHSSGAMPGSSLGSP	FAM193B	211	Q96PV7
GTHPPGSLPSMDSGS	FAM131C	256	Q96AQ9
ERTLSPGLPSGSMSP	HUNK	596	P57058
GHLMSALPASNPGPS	MAMLD1	441	Q13495
SRGLPPSSPMVSSAH	MARK4	466	Q96L34
FAVSPLGSPMSPHSL	MAST4	1101	O15021
LGSPMSPHSLSSDPS	MAST4	1106	O15021
HQAPSMLSPGPALSS	MAPKBP1	771	O60336
MEAPHPSLVLTSPGG	MBD5	116	Q9P267
SPTGRGSMAAPSLHP	RXRA	21	P19793
GSMAAPSLHPSLGPG	RXRA	26	P19793
TSTPGEGSTPLTSMP	MUC17	916	Q685J3
PLPTGSIHTTMSPTP	MUC3B	231	Q9H195
SSPTPGHQALPMPSS	TSGA10IP	126	Q3SY00
SPLGAPEHVSSPMSG	SMARCA2	126	P51531
HGNSAPSLLMPLPGT	SYNRG	491	Q9UMZ2
ALGQMPLSPDPSHTT	F5	1351	P12259
VSMSLTLGHLPPPSS	NHSL2	726	Q5HYW2
GTLSSGPPGHTMEVS	NDRG2	356	Q9UN36
ASSPPAVPSHSMVGI	RFX2	121	P48378
MSGSNSPHGSPTSPL	NEO1	1086	Q92859
LGGGSLPHPMLNPTS	PRDM1	451	O75626
SPRISSPMHPSAGGQ	SUPT5H	666	O00267
TTMPSSLPLGPGLGS	SMARCC2	1151	Q8TAQ2
SSPSSSGTPALPGHM	ACD	271	Q96AP0
HSLRSLTGMPPLSTP	CLEC16A	1016	Q2KHT3
LPSHVTPTTGVPTMS	CNOT2	106	Q9NZN8
SPGLGSLVSPHGPHM	RNF214	511	Q8ND24
NLHMAGLTASPTPPS	TLK1	746	Q9UKI8
PSPGLAGPVTMTSVH	TRIM24	666	O15164
PSLLTMASSPHGSPD	SPATA2	296	Q9UM82
PSATPGSLMSPLTGT	SPATC1	106	Q76KD6
GPTCMVLHPLAGSPS	STAR	221	P49675
LTATPTPLGGMTGFH	SF3B1	431	O75533
SSVPMPAGGKGSHPS	SPATA20	41	Q8TB22
GSSLSSSPMHGPPVA	WASF3	411	Q9UPY6
HPSLSPPSTMILSGG	PRRC2B	2001	Q5JSZ5
TDGGMSPSHPLGILT	PPP1R3F	516	Q6ZSY5
HPPMRATGLPSSLAS	TLE3	426	Q04726
HMPPLSLSPGSTDFS	ZZEF1	431	O43149
GKSPTSPTSPHMPAL	SOX5	406	P35711
SSTGMKHSSSAPPPP	WIPF2	166	Q8TF74
LSSGSHLPLPFPAGM	nan	111	Q6ZTC4
GLAALVMSPHAPSTP	ZAN	1011	Q9Y493